Compare
5 stocks, side by sideRelative performance · rebased to 100
RPRXONCRVMDMRNAALNY
| RPRXRoyalty Pharma plc | ONCBeOne Medicines AG | RVMDRevolution Medicines, Inc. | MRNAModerna | ALNYAlnylam Pharmaceuticals, Inc. | |
|---|---|---|---|---|---|
| Smart Score | 7/10 | 8/10 | 10/10 | 9/10 | 8/10 |
| Price | $54.69 | $275.34 | $178.17 | $60.42 | $293.17 |
| 1 month | +1.5% | -9.0% | +15% | +29% | -0.79% |
| 1 year | +55% | +3.2% | +345% | +135% | -9.8% |
| 5 year | +39% | -16% | +423% | -69% | +70% |
| P/E (TTM) | 29.3 | 50.9 | -27.6 | -7.4 | 67.8 |
| P/E vs sector | -7% | +62% | - | - | +115% |
| Market cap | $31.5B | $28.6B | $37.9B | $25.4B | $39.1B |
| Sector | Healthcare | Healthcare | Healthcare | Health Care | Healthcare |
Risk / Return · past yearAnnualized return vs volatility, up-and-left is more reward for less risk.
Correlation · do they move together?Pairwise daily-return correlation over the past year, high = one bet, low = diversifying.